Cytologic and immunophenotypic features of CD34+ stem cells in body cavity fluids

Acta Cytologica

Volumn 56, Issue 4, 2012, Pages 401-407

  Kataoka, Hideo ^a   Okabe, Hidetoshi ^b   Amano, Shigeru ^c   Yamada, Eiji ^a   Ishida, Mitsuaki ^b   Kushima, Ryoji ^d   Kobayashi, Tadao K ^e  

^a Hikone Municipal Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Institute for Nihon Cell Net Co Ltd   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e Medical Care Center   (Japan)

Author keywords

Body cavity fluid; CD34; Immunocytochemistry; Stem cells

Indexed keywords

CA 125 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD34 ANTIBODY; CD68 ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY D2-40; PEROXIDASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BODY FLUID; BONE MARROW CELL; CD34 SELECTION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; STAINING; STEM CELL;

EID: 84864192552     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000337452     Document Type: Article

References (18)

1. Zhao Y, Glesne D, Huberman E: A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003;100:2426-2431.
2. Kataoka H, Kobayashi TK, Amano S, Yamada E, Ishida M, Kushima R, Okabe H: Body cavity fluid can induce epithelial and mesothelial differentiation from CD34 positive peripheral blood stem cells in vitro. Cytopathology, E-pub ahead of print.
3. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-537.
4. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP: Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170.
5. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
6. Goyert SM, Ferrero E, Rettiq WJ, Yanamandra AK, Obata F, Le Beau MM: The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988;239:497-500.
7. Baumgartner I, Scheiner O, Holzinger C, Boltz-Nitulescu G, Klech H, Lassmann H, Rumpold H, Forster O, Kraft D: Expression of the VEP13 antigen (CD16) on native human alveolar macrophages and cultured blood monocytes. Immunobiology 1988;177:317-326.
8. Pulford KA, Sipos A, Cordell JL, Stross WP, Mason DY: Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 1990;2:973-980.
9. Osawa M, Hanada K, Hamada H, Nakauchi H: Long-term lymphohematopoietic reconstitution by a single CD34 low/negative hematopoietic stem cell. Science 1996;273:242-245.
10. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846.
11. Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H, Nakauchi H: Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 2006;25:3515-3523.
12. Corcoran JP, Ferretti P: Keratin 8 and 18 expression in mesenchymal progenitor cells of regenerating limbs is associated with cell proliferation and differentiation. Dev Dyn 1997;210:355-370.
13. Burnouf T, Lee CY, Luo CW, Kuo YP, Chou ML, Wu YW, Tseng YH, Su CY: Human blood-derived fibrin releasates: composition and use for the culture of cell lines and human primary cells. Biologicals 2012;40:21-30.
14. Ordóñez NG: D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 2005;36:372-380.
15. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ: Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005;18:105-110.
16. Dazzi H, Hasleton PS, Thatcher N: Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody. Br J Cancer 1990;61:924-926.
17. Ramael M, Seqers K, Buysse C, Van den Bossche J, Van Marck E: Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium. Virchows Arch A Pathol Anat Histopathol 1991;419:171-175.
18. Liu CD, Tilch L, Kwan D, McFadden DW: Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer. J Surg Res 2000;102:31-34.